The Lancet Commission on prostate cancer: planning for the surge in cases Published: April 4, 2024

https://www.thelancet.com/commissions/prostate-cancer?dgcid=hubspot_email_conferencealerts_lancetprostatecancer24&utm_campaign=conferencealerts&utm_medium=email&_hsenc=p2ANqtz-8uLZaNtifnUekufe5PPLb5NSvy-a9ABNz1sh2CE3_luXIBSwaDLLC2Mjd_2ERjd8IDLnpdrhnvtjI9jiyG-bOPBGkWZQ&_hsmi=299878153&utm_content=299878153&utm_source=hs_email Executive Summary Prostate cancer is already a major cause of morbidity and mortality worldwide and the prostate cancer commission projects that the number of new cases will double between 2020-2040. The commission analysis both immediate and long-term interventions to mitigate the current and projected future global impact of prostate cancer. The burden of disease globally is already substantial but there areas of cancer care highlighted by the commission, where technology, patient empowerment and simple practice change innovations can advance cancer control. Opportunities are available from the diagnostic pathway to the management of advanced disease and need to be urgently implemented to better prepare patients and healthcare providers, to respond to the current and future burden of prostate cancer. The Lancet Commission on prostate cancer provides an agenda for a realistic programme of changes, which, if implemented, will improve the health of men globally both now and in future.